Nexentis Technologies Inc. (NXTS)
Materials · NCM
Price as at 30 Sept 2026, 21:59 UTC. Quotes are delayed.
Fundamentals
Valuation and ratings
Nexentis Technologies Inc. trades at $1.39, which is 171% below the $3.76 our fair value estimate puts on the business. On that measure alone it screens as undervalued, though a valuation model is an argument rather than a measurement, and the market is frequently right about why something is cheap.
Our moat model scores it 10 out of 100, which is little in the way of a moat. A moat is a structural reason competitors cannot take the profits away, and it matters more to a long holding period than any single quarter's numbers do.
About Nexentis Technologies Inc.
Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects. The company's pipeline includes MITOLINE, an algorithm used to perform multiple sequence/ structure pairwise alignments which could then be used for generating a 3D comparative model of potentially all mitochondrial carrier proteins; cloud-based computational chemistry platform; and novel in-vitro screening platforms; and advanced 3D NSCLC tumor spheroid systems.The company was formerly known as N2OFF, Inc. and changed its name to Nexentis Technologies Inc. in February 2026. Nexentis Technologies Inc. was incorporated in 2009 and is headquartered in Ness Ziona, Israel.
Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.
NXTS passes 2 of our 30 screens today
Each screen prints the exact criteria it used, and the circumstances in which it is wrong.
NXTS peers
The largest companies in the same industry (Agricultural Inputs), then in the same sector.
- NTR Nutrien Ltd.
- CF CF Industries Holdings, Inc.
- YARIY Yara International ASA
- MOS The Mosaic Company
- ICL ICL Group Ltd
- FMC FMC Corporation
- IPI Intrepid Potash, Inc.
- AVD American Vanguard Corporation
Every materials company we cover is on the Materials hub.
Common questions
Is Nexentis Technologies Inc. (NXTS) undervalued?
Against our fair value estimate of $3.76, NXTS at $1.39 is 171% below fair value. That is one model's answer, not a recommendation. It is built from normalized earning power with growth capped deliberately low, which understates companies whose value is mostly future growth.
Where does SteadyShares get its NXTS data?
Fundamentals for NXTS come from company filings and exchange data, as listed on NCM; institutional ownership comes from SEC 13F filings. The share price shown was last refreshed on 30 Sept 2026, 21:59 UTC and is delayed. Our data quality score for this company is 75/100, which is the share of the inputs behind our scores that were actually available rather than assumed. Metrics we do not hold are left out of the page rather than estimated.
The full research page for NXTS, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.
Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.